12 Health Care Stocks Moving In Friday's After-Market Session
I'm LongbridgeAI, I can summarize articles.During Friday's after-market session, several healthcare stocks experienced significant volatility. Picard Medical surged 40.2% to $4.5 following its Q2 earnings report. Other gainers included Stablecoin Development (+10.52%), Z Squared (+6.84%), CDT Equity (+6.29%), Enlivex (+5.42%), and BioAtla (+5.34%). Conversely, CytoMed Therapeutics dropped 15.7%, while Pasithea Therapeutics, ALPS Group, Vivos Therapeutics, HeartSciences, and Addex Therapeutics also saw declines ranging from 4.86% to 9.16%.
Gainers
- Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session. The company's market cap stands at $6.2 million. As per the news, the Q2 earnings report came out 2 days ago.
- Stablecoin Development (AMEX:SDEV) shares rose 10.52% to $1.26. The market value of their outstanding shares is at $30.3 million.
- Z Squared (NASDAQ:ZSQR) shares moved upwards by 6.84% to $3.9. The market value of their outstanding shares is at $209.8 million.
- CDT Equity (NASDAQ:CDT) shares increased by 6.29% to $3.04. The company's market cap stands at $2.2 million.
- Enlivex (NASDAQ:ENLV) stock rose 5.42% to $1.55. The market value of their outstanding shares is at $26.2 million.
- BioAtla (NASDAQ:BCAB) stock increased by 5.34% to $3.35. The market value of their outstanding shares is at $5.2 million.
Losers
- CytoMed Therapeutics (NASDAQ:GDTC) stock decreased by 15.7% to $0.85 during Friday's after-market session. The market value of their outstanding shares is at $10.6 million.
- Pasithea Therapeutics (NASDAQ:KTTA) stock fell 9.16% to $0.49. The market value of their outstanding shares is at $15.7 million.
- ALPS Group (NASDAQ:ALPS) stock fell 7.69% to $0.3. The company's market cap stands at $44.9 million.
- Vivos Therapeutics (NASDAQ:VVOS) shares declined by 5.63% to $0.28. The market value of their outstanding shares is at $5.6 million.
- HeartSciences (NASDAQ:HSCS) stock declined by 5.15% to $2.66. The company's market cap stands at $9.7 million.
- Addex Therapeutics (NASDAQ:ADXN) shares declined by 4.86% to $4.7. The market value of their outstanding shares is at $5.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.